Y Intercept Hong Kong Ltd raised its stake in Colgate-Palmolive Company (NYSE:CL – Free Report) by 152.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 167,905 shares of the company’s stock after buying an additional 101,472 shares during the period. Y Intercept Hong Kong Ltd’s holdings in Colgate-Palmolive were worth $13,422,000 as of its most recent SEC filing.
A number of other hedge funds also recently made changes to their positions in CL. Norges Bank bought a new stake in Colgate-Palmolive in the second quarter valued at approximately $960,390,000. Schroder Investment Management Group raised its holdings in Colgate-Palmolive by 242.3% during the 2nd quarter. Schroder Investment Management Group now owns 5,324,115 shares of the company’s stock worth $483,962,000 after purchasing an additional 3,768,784 shares during the last quarter. Pacer Advisors Inc. lifted its position in shares of Colgate-Palmolive by 3,052.2% in the 3rd quarter. Pacer Advisors Inc. now owns 2,697,047 shares of the company’s stock worth $215,602,000 after purchasing an additional 2,611,485 shares during the period. Acadian Asset Management LLC boosted its stake in shares of Colgate-Palmolive by 42.9% in the 2nd quarter. Acadian Asset Management LLC now owns 6,124,347 shares of the company’s stock valued at $556,663,000 after purchasing an additional 1,839,853 shares during the last quarter. Finally, OMERS ADMINISTRATION Corp increased its position in shares of Colgate-Palmolive by 2,890.5% during the second quarter. OMERS ADMINISTRATION Corp now owns 1,417,542 shares of the company’s stock worth $128,855,000 after buying an additional 1,370,140 shares during the period. 80.41% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
CL has been the topic of several recent analyst reports. Weiss Ratings restated a “hold (c)” rating on shares of Colgate-Palmolive in a report on Wednesday. The Goldman Sachs Group lowered their price objective on Colgate-Palmolive from $106.00 to $91.00 and set a “buy” rating for the company in a research report on Thursday, October 2nd. Royal Bank Of Canada raised Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 price objective on the stock in a research note on Tuesday, December 9th. UBS Group raised their target price on Colgate-Palmolive from $90.00 to $93.00 and gave the stock a “buy” rating in a research note on Wednesday, January 14th. Finally, Morgan Stanley lowered their target price on Colgate-Palmolive from $96.00 to $87.00 and set an “overweight” rating for the company in a report on Monday, November 3rd. Eleven investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat, Colgate-Palmolive has an average rating of “Moderate Buy” and a consensus target price of $89.44.
Colgate-Palmolive Price Performance
Shares of CL opened at $86.67 on Friday. The business’s fifty day moving average is $80.07 and its 200 day moving average is $81.58. Colgate-Palmolive Company has a 12-month low of $74.54 and a 12-month high of $100.18. The company has a quick ratio of 0.60, a current ratio of 0.93 and a debt-to-equity ratio of 5.90. The stock has a market cap of $69.86 billion, a P/E ratio of 24.28, a P/E/G ratio of 5.82 and a beta of 0.30.
Colgate-Palmolive (NYSE:CL – Get Free Report) last released its quarterly earnings data on Friday, October 31st. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.89 by $0.02. Colgate-Palmolive had a net margin of 14.47% and a return on equity of 333.39%. The firm had revenue of $5.13 billion for the quarter, compared to the consensus estimate of $5.17 billion. During the same quarter in the prior year, the company posted $0.91 earnings per share. The business’s revenue was up 1.9% on a year-over-year basis. Sell-side analysts anticipate that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.
Colgate-Palmolive Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 21st will be issued a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date is Wednesday, January 21st. Colgate-Palmolive’s dividend payout ratio is currently 58.26%.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.
The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.
Read More
- Five stocks we like better than Colgate-Palmolive
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- The $100 Trillion AI Story No One Is Telling You
- Is Your Brokerage on This List?
- Trump’s AI Secret: 100X Faster Than Nvidia
- Buy This Stock at 9:30 AM on MONDAY!
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
